These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22252471)

  • 1. Mice expressing a human K(ATP) channel mutation have altered channel ATP sensitivity but no cardiac abnormalities.
    Clark R; Männikkö R; Stuckey DJ; Iberl M; Clarke K; Ashcroft FM
    Diabetologia; 2012 Apr; 55(4):1195-204. PubMed ID: 22252471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes.
    Girard CA; Wunderlich FT; Shimomura K; Collins S; Kaizik S; Proks P; Abdulkader F; Clark A; Ball V; Zubcevic L; Bentley L; Clark R; Church C; Hugill A; Galvanovskis J; Cox R; Rorsman P; Brüning JC; Ashcroft FM
    J Clin Invest; 2009 Jan; 119(1):80-90. PubMed ID: 19065048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP.
    Proks P; Girard C; Ashcroft FM
    Hum Mol Genet; 2005 Sep; 14(18):2717-26. PubMed ID: 16087682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-sensitive K+ channels: implications in disease mechanism and sulfonylurea therapy.
    Lin CW; Lin YW; Yan FF; Casey J; Kochhar M; Pratt EB; Shyng SL
    Diabetes; 2006 Jun; 55(6):1738-46. PubMed ID: 16731837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
    Proks P; Antcliff JF; Lippiat J; Gloyn AL; Hattersley AT; Ashcroft FM
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17539-44. PubMed ID: 15583126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diazoxide maintenance of myocyte volume and contractility during stress: evidence for a non-sarcolemmal K(ATP) channel location.
    Sellitto AD; Maffit SK; Al-Dadah AS; Zhang H; Schuessler RB; Nichols CG; Lawton JS
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1153-9. PubMed ID: 20804990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes.
    Proks P; de Wet H; Ashcroft FM
    Diabetes; 2013 Nov; 62(11):3909-19. PubMed ID: 23835339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique properties of the ATP-sensitive K⁺ channel in the mouse ventricular cardiac conduction system.
    Bao L; Kefaloyianni E; Lader J; Hong M; Morley G; Fishman GI; Sobie EA; Coetzee WA
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):926-35. PubMed ID: 21984445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in the ATP-binding site of the Kir6.2 subunit of the KATP channel alters coupling with the SUR2A subunit.
    Tammaro P; Ashcroft FM
    J Physiol; 2007 Nov; 584(Pt 3):743-53. PubMed ID: 17855752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the K(ATP) channel by Mg-nucleotide interaction with SUR1.
    Proks P; de Wet H; Ashcroft FM
    J Gen Physiol; 2010 Oct; 136(4):389-405. PubMed ID: 20876358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.
    Pratt EB; Tewson P; Bruederle CE; Skach WR; Shyng SL
    J Gen Physiol; 2011 Mar; 137(3):299-314. PubMed ID: 21321069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP and sulfonylurea sensitivity of mutant ATP-sensitive K+ channels in neonatal diabetes: implications for pharmacogenomic therapy.
    Koster JC; Remedi MS; Dao C; Nichols CG
    Diabetes; 2005 Sep; 54(9):2645-54. PubMed ID: 16123353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
    Proks P; Girard C; Baevre H; Njølstad PR; Ashcroft FM
    Diabetes; 2006 Jun; 55(6):1731-7. PubMed ID: 16731836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance for ATP-insensitive K(ATP) channels in transgenic mice.
    Koster JC; Knopp A; Flagg TP; Markova KP; Sha Q; Enkvetchakul D; Betsuyaku T; Yamada KA; Nichols CG
    Circ Res; 2001 Nov; 89(11):1022-9. PubMed ID: 11717159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMR 1098 is not an SUR isotype specific inhibitor of heterologous or sarcolemmal K ATP channels.
    Zhang HX; Akrouh A; Kurata HT; Remedi MS; Lawton JS; Nichols CG
    J Mol Cell Cardiol; 2011 Mar; 50(3):552-60. PubMed ID: 21185839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.
    Slingerland AS; Nuboer R; Hadders-Algra M; Hattersley AT; Bruining GJ
    Diabetologia; 2006 Nov; 49(11):2559-63. PubMed ID: 17047922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
    Reimann F; Dabrowski M; Jones P; Gribble FM; Ashcroft FM
    J Physiol; 2003 Feb; 547(Pt 1):159-68. PubMed ID: 12562963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
    Flechtner I; de Lonlay P; Polak M
    Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the mechanism of metabolic regulation of ATP-sensitive K+ channels containing Kir6.1 and Kir6.2 subunits.
    Farzaneh T; Tinker A
    Cardiovasc Res; 2008 Sep; 79(4):621-31. PubMed ID: 18522960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cardiac ATP-sensitive potassium channel surface expression by calcium/calmodulin-dependent protein kinase II.
    Sierra A; Zhu Z; Sapay N; Sharotri V; Kline CF; Luczak ED; Subbotina E; Sivaprasadarao A; Snyder PM; Mohler PJ; Anderson ME; Vivaudou M; Zingman LV; Hodgson-Zingman DM
    J Biol Chem; 2013 Jan; 288(3):1568-81. PubMed ID: 23223335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.